Provention Bio Inc. (PRVB) Fundamentals

Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-6527, PRV-300, and PRV-101.
SHARE INFORMATION
Market Cap$ 259,362,875
Shares Outstanding64,040,216
Float58,407,444
Percent Float91.2%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,395,000
Latest Fiscal EPS$ -1.81
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions286
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months923,105
Institutional Holdings Percent66.4%
Institutional Sold Previous 3 Months5,784,924
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months267,000
Insider Holdings Percent10.5
Insider Sold Previous 3 Months-
Insider Shares Owned6,723,087
TRADING INFO
52 Week High$ 9.70
52 Week Low$ 3.40
52 Week High Change$ -51.67
21 Day Moving Average$ 3.9729
21 Day Extended Moving Average$ 4.0271
50 Day Moving Average$ 4.4867
50 Day Extended Moving Average$ 4.5279
200 Day Moving Average$ 5.8085
200 Day Extended Moving Average$ 5.9584
10 Day Average Volume623,478
20 Day Average Volume602,410
30 Day Average Volume619,727
50 Day Average Volume561,366
Alpha0.014891
Beta2.7454
Standard Deviation0.347886
R20.172667
7 Day Price Change$ 0.37
7 Day Percent Change10.05%
21 Day Price Change$ 0.20
21 Day Percent Change5.19%
30 Day Price Change$ 0.06
30 Day Percent Change1.5%
Month to Date Price Change$ -0.07
Month to Date Percent Change-1.7%
Quarter to Date Price Change$ -3.27
Quarter to Date Percent Change-44.67%
180 Day Price Change$ -2.13
180 Day Percent Change-34.47%
200 Day Price Change$ -2.40
200 Day Percent Change-37.21%
Year to Date Price Change$ -1.57
Year to Date Percent Change-27.94%

Provention Bio Inc. (PRVB) Key Ratios

PROFITABILITY
EBIT Margin-5,680.6%
EBITDA Margin-5,657.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,975,000
Revenue Per Share$ 0.0308
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio3.40
Leverage Ratio1.20
Quick Ratio3.10
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-2.40
Enterprise Value$ 166,550,646
Price to Sales131.323
Price to Free Cash-2.70
PE High Last 5 Years0.00
Price To Book2.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-64.11
Return on Equity-77.63
Return on Capital-74.56

Provention Bio Inc. (PRVB) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorEisnerAmper LLP
CEOAshleigh Palmer
Emplyoees82
Last AuditUQ
CIK0001695357
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address55 Broad Street
2nd floor
Red Bank, NJ 7701
Websitehttps://www.proventionbio.com
Facsimile-
Telephone+1 908 336-0360
Emailinfo@proventionbio.com


Your Recent History
NASDAQ
PRVB
Provention..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.